Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross J Baldessarini

Showing results (1-10 of 368) with videos related to

Pageof 37
Sort By:
Bipolar Disorders|April 19, 2003
Assessment of treatment response in mania: commentary and new findingsRoss J Baldessarini
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 28, 2014
The impact of psychopharmacology on contemporary psychiatryRoss J Baldessarini
Drug Safety|November 10, 2012
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysisRoss J Baldessarini
The Journal of Clinical Psychiatry|June 11, 2011
Suicidal risk during antidepressant treatmentRoss J Baldessarini
The New England Journal of Medicine|May 15, 2009
Atypical antipsychotic drugs and the risk of sudden cardiac deathRoss J Baldessarini
The Journal of Clinical Psychiatry|January 1, 2015
Risks in discontinuation trials with antidepressantsRoss J Baldessarini
CNS Drugs|October 18, 2002
Treatment research in bipolar disorder: issues and recommendationsRoss J Baldessarini
Bipolar Disorders|November 12, 2010
Commentary: the Bipolar Affective Disorder: Lithium/Anticonvulsant Evaluation (BALANCE) studyRoss J Baldessarini
Journal of Clinical Psychopharmacology|November 18, 2008
Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression"Ross J Baldessarini
Revista De Psiquiatria Y Salud Mental|March 1, 2013
Commentary: the current state of psychopharmacology and psychiatryRoss J Baldessarini
Pageof 37

Showing results (1-10 of 368) with videos related to

Sort By:
Pageof 37
Bipolar Disorders|April 19, 2003
Assessment of treatment response in mania: commentary and new findingsRoss J Baldessarini
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 28, 2014
The impact of psychopharmacology on contemporary psychiatryRoss J Baldessarini
Drug Safety|November 10, 2012
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysisRoss J Baldessarini
The Journal of Clinical Psychiatry|June 11, 2011
Suicidal risk during antidepressant treatmentRoss J Baldessarini
The New England Journal of Medicine|May 15, 2009
Atypical antipsychotic drugs and the risk of sudden cardiac deathRoss J Baldessarini
The Journal of Clinical Psychiatry|January 1, 2015
Risks in discontinuation trials with antidepressantsRoss J Baldessarini
CNS Drugs|October 18, 2002
Treatment research in bipolar disorder: issues and recommendationsRoss J Baldessarini
Bipolar Disorders|November 12, 2010
Commentary: the Bipolar Affective Disorder: Lithium/Anticonvulsant Evaluation (BALANCE) studyRoss J Baldessarini
Journal of Clinical Psychopharmacology|November 18, 2008
Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression"Ross J Baldessarini
Revista De Psiquiatria Y Salud Mental|March 1, 2013
Commentary: the current state of psychopharmacology and psychiatryRoss J Baldessarini
Pageof 37